Delivery Order SPE2DB22D1106-SPE2DB25FDXB6
Award Date
2/2/25
Potential Completion Date
2/3/25
Potential Value
$3.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the medical product ZYNRELEF 400-12 MG/14 ML VIAL 14ML, with a ceiling value of $1,901.50 and a completion date of January 7, 2025. The contract is a Firm Fixed Price type, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the delivery of ZYNRELEF 200-6 MG/7 ML VIAL 7ML under a Delivery Order contract with the Defense Logistics Agency (DLA) Troop Support Medical. The $1,888.39 firm fixed price award has an ultimate completion date of October 31, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical running through November 2026, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $5,162.59 firm-fixed-price delivery order is for the supply of ZYNRELEF 400-12 MG/14 ML VIAL 14ML, a pain medication. The award does not utilize a set-aside. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025, which serves as a primary vehicle...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,485.96, is for the delivery of ZILRETTA 32 MG VIALS, a specialty pharmaceutical product. The contract has an ultimate completion date of March 25, 2025 and is a Firm Fixed Price Delivery Order. The contract was not set aside for any specific business type. AmerisourceBergen holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ZILRETTA 32 MG VIALS. The contract has a ceiling value of $1,402.28 and a completion date of December 4, 2024. It is a Firm Fixed Price contract, with no set-aside designation. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,503.56, is for the procurement of ZYMFENTRA 120 MG/ML PEN KITS, a medical supply item. The contract is a firm fixed price delivery order with a completion date of February 7, 2025. This contract is not set aside for any specific business type....
This is a delivery order for Zilretta 32 mg vials awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office Division. The $1,051.71 firm-fixed-price contract has a completion date of September 13, 2024. AmerisourceBergen is a major supplier of pharmaceuticals and medical supplies to federal agencies, including the military. The company holds several Indefinite Delivery Contracts (IDCs) with the DLA and Department of Justice Federal Bureau of...
This is a delivery order awarded to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA), a defense agency, for the supply of ZILRETTA 32 MG VIALS. The award, valued at $1,752.85, is a firm fixed-price contract with a completion date of May 29, 2024. This delivery order falls under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. The...
This is a federal delivery order contract awarded to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA), a defense agency. The contract is for the provision of ZILRETTA 32 MG VIALS, a pharmaceutical product. The contract has a ceiling value of $1,752.85 and a period of performance ending on June 13, 2024. Amerisourcebergen, a large pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
The Defense Logistics Agency (DLA) awarded a $1,503.56 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide ZYMFENTRA 120 MG/ML PEN KITS. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle for the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military...